Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques

The melanocortin-4 receptor (MC4R) is well recognized as an important mediator of body weight homeostasis. Activation of MC4R causes dramatic weight loss in rodent models, and mutations in human are associated with obesity. This makes MC4R a logical target for pharmacological therapy for the treatment of obesity. However, previous studies in rodents and humans have observed a broad array of side effects caused by acute treatment with MC4R agonists, including increased heart rate and blood pressure. We demonstrate that treatment with a highly-selective novel MC4R agonist (BIM-22493 or RM-493) resulted in transient decreases in food intake (35%), with persistent weight loss over 8 weeks of treatment (13.5%) in a diet-induced obese nonhuman primate model. Consistent with weight loss, these animals significantly decreased adiposity and improved glucose tolerance. Importantly, we observed no increases in blood pressure or heart rate with BIM-22493 treatment. In contrast, treatment with LY2112688, an MC4R agonist previously shown to increase blood pressure and heart rate in humans, caused increases in blood pressure and heart rate, while modestly decreasing food intake. These studies demonstrate that distinct melanocortin peptide drugs can have widely different efficacies and side effects.

[1]  K. Hofbauer,et al.  Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in rats , 2010, Journal of receptor and signal transduction research.

[2]  J. Cameron,et al.  A rapidly occurring compensatory decrease in physical activity counteracts diet-induced weight loss in female monkeys. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  J. Hoyer,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  H. Grill,et al.  Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins. , 2009, Endocrinology.

[5]  M. Culler,et al.  Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice , 2009, Peptides.

[6]  H. Grill,et al.  Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors. , 2009, Endocrinology.

[7]  Sarah M. Williams,et al.  Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. , 2009, The Journal of clinical investigation.

[8]  A. A. da Silva,et al.  Endogenous Melanocortin System Activity Contributes to the Elevated Arterial Pressure in Spontaneously Hypertensive Rats , 2008, Hypertension.

[9]  S. O’Rahilly,et al.  The central melanocortin system directly controls peripheral lipid metabolism. , 2007, The Journal of clinical investigation.

[10]  K. Cheng,et al.  Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness , 2007, Diabetologia.

[11]  R. Cone,et al.  Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. , 2007, Endocrinology.

[12]  J. Baik,et al.  Peripheral Effect of α-Melanocyte-stimulating Hormone on Fatty Acid Oxidation in Skeletal Muscle* , 2007, Journal of Biological Chemistry.

[13]  R. Cone,et al.  Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones , 2006, Journal of hypertension.

[14]  Jiankang Liu,et al.  Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? , 2006, Hypertension.

[15]  K. Hofbauer,et al.  Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive rats , 2006, Peptides.

[16]  A. Pocai,et al.  Central leptin acutely reverses diet-induced hepatic insulin resistance. , 2005, Diabetes.

[17]  S. Morrison,et al.  Regulation of thermogenesis by the central melanocortin system , 2005, Peptides.

[18]  H. Berthoud,et al.  Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. , 2005, Endocrinology.

[19]  D. Stec,et al.  Melanocortin-4 Receptor–Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia , 2005, Hypertension.

[20]  H. Berthoud,et al.  Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  J. Speakman,et al.  Peripherally administered [Nle4,D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice. , 2004, Journal of molecular endocrinology.

[22]  A. A. da Silva,et al.  Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin , 2004, Hypertension.

[23]  J. Kuo,et al.  Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation , 2004, Hypertension.

[24]  J. Wild,et al.  Melanocortin-4 receptor messenger ribonucleic acid expression in rat cardiorespiratory, musculoskeletal, and integumentary systems. , 2003, Endocrinology.

[25]  H. Grill,et al.  Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. , 2003, Endocrinology.

[26]  J. Fenyk-Melody,et al.  Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats , 2003, Brain Research.

[27]  H. Schiöth,et al.  Role of MC4 receptors in the depressor and bradycardic effects of &agr;-MSH in the nucleus tractus solitarii of the rat , 2003, Neuroreport.

[28]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[29]  J. Kuo,et al.  Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function , 2003, Hypertension.

[30]  L. Rossetti,et al.  Central melanocortin receptors regulate insulin action. , 2001, The Journal of clinical investigation.

[31]  J. Cameron,et al.  Central melanocortin receptors mediate changes in food intake in the rhesus macaque. , 2001, Endocrinology.

[32]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[33]  M. Low,et al.  Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.

[34]  S. Woods,et al.  Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  R. Cone,et al.  Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus Evidence of a Cellular Basis for the Adipostat , 1999, Neuron.

[36]  H. Grill,et al.  Brainstem Application of Melanocortin Receptor Ligands Produces Long-Lasting Effects on Feeding and Body Weight , 1998, The Journal of Neuroscience.

[37]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[38]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[39]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[40]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[41]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[42]  A. Vergoni,et al.  ACTH-(1–24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists , 1986, Peptides.

[43]  D. Schoeller,et al.  Validation of doubly labeled water for measuring energy expenditure during parenteral nutrition. , 1986, The American journal of clinical nutrition.

[44]  S. O’Rahilly,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, The New England journal of medicine.

[45]  J. Baik,et al.  Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. , 2007, The Journal of biological chemistry.

[46]  R. Weindruch,et al.  Energy expenditure of rhesus monkeys subjected to 11 years of dietary restriction. , 2003, The Journal of clinical endocrinology and metabolism.

[47]  M. Castro,et al.  Post-translational processing of proopiomelanocortin in the pituitary and in the brain. , 1997, Critical reviews in neurobiology.

[48]  A. Vergoni,et al.  ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. , 1986, Peptides.